A new trading day began on Tuesday, with Organogenesis Holdings Inc (NASDAQ: ORGO) stock price down -7.85% from the previous day of trading, before settling in for the closing price of $5.99. ORGO’s price has ranged from $2.61 to $7.08 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 1617.00%. With a float of $59.79 million, this company’s outstanding shares have now reached $126.91 million.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 52.89%, while institutional ownership is 54.12%. The most recent insider transaction that took place on May 14 ’25, was worth 775,041. In this transaction Director of this company bought 251,001 shares at a rate of $3.09, taking the stock ownership to the 251,001 shares. Before that another transaction happened on May 15 ’25, when Company’s Director bought 107,494 for $2.99, making the entire transaction worth $320,999. This insider now owns 358,495 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.07 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1617.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Here are Organogenesis Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 0.18 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 1.39 million, a negative change from its year-to-date volume of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 62.71%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 55.47%, which indicates a significant increase from 51.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was higher than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.60, while its 200-day Moving Average is $4.30. Nevertheless, the first resistance level for the watch stands at $5.87 in the near term. At $6.23, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.46. If the price goes on to break the first support level at $5.28, it is likely to go to the next support level at $5.05. The third support level lies at $4.69 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
With a market capitalization of 700.55 million, the company has a total of 126,912K Shares Outstanding. Currently, annual sales are 482,040 K while annual income is 860 K. The company’s previous quarter sales were 150,860 K while its latest quarter income was 21,570 K.
